Acquisitions thérapeutiques 1983 = New drugs in 1983Médecine et hygiène. 1984, Vol 42, Num 1546, pp 3-87, issn 0025-6749Article

New Drugs and New Molecular Entities in DermatologyEAGLSTEIN, William H; CORCORAN, Gavin.Archives of dermatology (1960). 2011, Vol 147, Num 5, pp 568-572, issn 0003-987X, 5 p.Article

New FDA Breakthrough-Drug Category — Implications for PatientsDARROW, Jonathan J; AVORN, Jerry; KESSELHEIM, Aaron S et al.The New England journal of medicine. 2014, Vol 370, Num 13, pp 1252-1258, issn 0028-4793, 7 p.Article

Strategies for improving drug development in the early phaseGRIGOLEIT, H.-G.Pharmazeutische Industrie. 1984, Vol 46, Num 5, pp 521-525, issn 0031-711XArticle

The 10 X '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020Clinical infectious diseases. 2010, Vol 50, Num 8, pp 1081-1083, issn 1058-4838, 3 p.Article

New Antithrombotic DrugsGROSS, P. L; WEITZ, J. I.Clinical pharmacology and therapeutics. 2009, Vol 86, Num 2, pp 139-146, issn 0009-9236, 8 p.Article

Utility of alkylaminoquinolinyl methanols as new antimalarial drugsDOW, G. S; HEADY, T. N; SMITH, P. L et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 12, pp 4132-4143, issn 0066-4804, 12 p.Article

Pharmaceutical Innovation in the 21 st Century: New Drug Approvals in the First Decade, 2000―2009KAITIN, K. I; DIMASI, J. A.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 2, pp 183-188, issn 0009-9236, 6 p.Article

New drugs for old: disinvestment and NICEHUGHES, Dyfrig; FERNER, Robin.BMJ. British medical journal (International ed.). 2010, Vol 340, Num 7748, pp 690-692, issn 0959-8146, 3 p.Article

Douteurs neuropathiques : contexte nouveaux outils, nouveaux médicamentsKUNTZER, T; DECOSTERD, I.Revue médicale suisse. 2005, Vol 1, Num 43, pp 2812-2816, issn 1660-9379, 5 p.Article

Développements nouveaux et prospectives dans la thérapie antifongique = Developments and prospective in antifungal therapyCAUWENBERGH, G.Bulletin de la Société française de mycologie médicale. 1984, Vol 13, Num 2, pp 415-424, issn 0037-9336Article

New anticancer drugsKISNER, D. L; KUHN, J. G; WEISS, G. R et al.Cancer chemotherapy. 1983, Num 5, pp 120-160Article

New lipid-lowering drugs: an updateWIERZBICKI, A. S; HARDMAN, T. C; VILJOEN, A et al.International journal of clinical practice (Esher). 2012, Vol 66, Num 3, pp 270-280, issn 1368-5031, 11 p.Article

Oxytocin : new perspectives on an old drugCLARK, Steven L; SIMPSON, Kathleen Rice; KNOX, G. Eric et al.American journal of obstetrics and gynecology. 2009, Vol 200, Num 1, pp 35-37, issn 0002-9378, 3 p.Article

A proteomic approach to identifying new drug targets (potentiating topoisomerase II poisons)JENKINS, J. R.British journal of radiology. 2008, Vol 81, issn 0007-1285, S69-S77, NS1Conference Paper

Contemporary drug development-dilemmasCUATRECASAS, P.Regulatory toxicology and pharmacology (Print). 1984, Vol 4, Num 1, pp 1-12, issn 0273-2300Article

Fortschritte auf dem Gebiet der Arzneimittelentwicklung. XVI = Développement de nouveaux médicaments = Progress in the field of drug development. XVDELENK-HEYDENREICH, K; HENKLER, G; KELLER, U et al.Pharmazie. 1983, Vol 38, Num 10, pp 646-662, issn 0031-7144Article

How the search for new drugs for neglected diseases is paying offHOPKINS TANNE, Janice.BMJ (Overseas and retired doctors ed.). 2012, Vol 344, Num 7852, pp 18-19, issn 1759-2151, 2 p.Article

Speeding up access to new drugsHAWKES, Nigel.BMJ (Overseas and retired doctors ed.). 2012, Vol 344, Num 7848, issn 1759-2151, p. 21Article

New image for the drug industryCOHEN, Deborah.BMJ (Overseas and retired doctors ed.). 2011, Vol 343, Num 7834, pp 1140-1141, issn 1759-2151, 2 p.Article

Cardiac repolarization and the safety of new drugs defined by electrocardiographyMORGANROTH, J.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 1, pp 108-113, issn 0009-9236, 6 p.Article

Current leads in antiviral chemotherapyDE CLERCQ, E.Journal of antimicrobial chemotherapy (Print). 1986, Vol 17, Num 4, pp 399-402, issn 0305-7453Article

New drug applications: how long to gain approval?SPIVEY, R. N; LASAGNA, L; TRIMBLE, A. G et al.Clinical pharmacology and therapeutics. 1985, Vol 37, Num 4, pp 361-366, issn 0009-9236Article

La pharmacie galénique dans le développement de nouveaux médicaments. DiscussionDELATTRE, L; EVRARD, Ph; MOLLE, L et al.Bulletin et mémoires de l'Académie Royale de Médecine de Belgique. 2007, Vol 162, Num 1-2, pp 141-150, issn 0377-8231, 10 p.Article

Where are those new antidepressants we were promised?COLE, J. O.Archives of general psychiatry. 1988, Vol 45, Num 2, pp 193-194, issn 0003-990XArticle